Abstract
Objectives: Autoimmune gastritis (AIG) is characterized by immune‐mediated destruction of gastric parietal cells and impaired iron absorption. Refractory iron deficiency anemia (IDA) is often the main clinical presentation in pediatric patients. Because oral ferrous glycine sulfate (FGS) is absorbed independently of gastric pH, it may represent an effective alternative to ferric hydroxide (FH) in this setting. Aim: To compare the therapeutic response to FH and FGS in children and adolescents with AIG‐associated IDA. Methods: We conducted a retrospective observational cohort study including pediatric patients diagnosed with AIG‐associated IDA and followed at a tertiary Pediatric Gastroenterology Unit between 2007 and 2023. Treatment non‐response was defined as a hemoglobin (Hb) increase p < 0.001), with normalization of Hb and ferritin achieved in 86% and 81% of patients, respectively. Two patients treated initially with FGS also demonstrated favorable hematologic responses. Conclusions: In this retrospective cohort, FGS was associated with substantial hematologic improvement in pediatric patients with AIG‐associated IDA, particularly in those who had failed previous FH therapy.

This publication has 6 references indexed in Scilit: